$SVA
SINOVAC BIOTECH LTD Stock $sva

$sva Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000095017024049936 Filed on April 29, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$307.9M	$448.3M
YoY Change	9.77%	-69.97%
Cost Of Revenue	-$6.893M	$181.5M
YoY Change	-101.6%	-73.48%
Gross Profit	$314.8M	$266.8M
YoY Change	-310.37%	-67.0%
Gross Profit Margin	102.24%	59.51%
Selling, General & Admin	$237.5M	$466.3M
YoY Change	-64.61%	-43.38%
% of Gross Profit	75.46%	174.81%
Research & Development	$193.4M	$344.5M
YoY Change	-24.96%	-22.07%
% of Gross Profit	61.44%	129.15%
Depreciation & Amortization	$60.75M	$140.5M
YoY Change	-22.95%	-8.68%
% of Gross Profit	19.3%	52.66%
Operating Expenses	$408.6M	$869.8M
YoY Change	-55.98%	-31.75%
Operating Profit	-$93.82M	-$603.0M
YoY Change	-91.29%	29.39%
Interest Expense	$53.53M	$82.85M
YoY Change	-49.59%	-56.29%
% of Operating Profit
Other Income/Expense, Net	$29.28M	$367.1M
YoY Change	-59.5%	21.67%
Pretax Income	-$89.42M	-$153.0M
YoY Change	-90.08%	-706.36%
Income Tax	$138.9M	$105.3M
% Of Pretax Income
Net Earnings	-$119.9M	-$99.92M
YoY Change	-67.92%	-187.75%
Net Earnings / Revenue	-38.93%	-22.29%
Basic Earnings Per Share		-$1.06
Diluted Earnings Per Share	-$1.20	-$1.06
COMMON SHARES
Basic Shares Outstanding	99.64M	99.61M
Diluted Shares Outstanding		99.61M

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.22B	$11.22B
YoY Change	-0.79%	-0.79%
Cash & Equivalents	$1.270B	$1.270B
Short-Term Investments	$9.953B	$9.953B
Other Short-Term Assets	$16.79M	$16.79M
YoY Change	-28.55%	-28.55%
Inventory	$139.9M	$139.9M
Prepaid Expenses
Receivables	$440.0M	$426.0M
Other Receivables	$10.70M	$24.71M
Total Short-Term Assets	$11.83B	$11.83B
YoY Change	-2.44%	-2.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$979.6M	$1.025B
YoY Change	-1.43%	-2.59%
Goodwill
YoY Change
Intangibles	$8.520M
YoY Change	-12.16%
Long-Term Investments	$684.3M	$684.3M
YoY Change	3.45%	3.45%
Other Assets	$7.345M	$109.5M
YoY Change	162.51%	-58.64%
Total Long-Term Assets	$1.827B	$1.827B
YoY Change	-8.09%	-8.09%
TOTAL ASSETS
Total Short-Term Assets	$11.83B	$11.83B
Total Long-Term Assets	$1.827B	$1.827B
Total Assets	$13.66B	$13.66B
YoY Change	-3.23%	-3.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$973.9M	$17.29M
YoY Change	7.51%	-12.78%
Accrued Expenses	$250.6M	$258.0M
YoY Change	3.31%	3.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$76.09M	$76.09M
YoY Change	1535.97%	1535.97%
Total Short-Term Liabilities	$1.148B	$1.148B
YoY Change	5.15%	5.15%
LONG-TERM LIABILITIES
Long-Term Debt	$177.8M	$177.8M
YoY Change	1444.49%	1444.49%
Other Long-Term Liabilities	$439.0K	$45.78M
YoY Change	82.92%	-20.02%
Total Long-Term Liabilities	$487.3M	$223.6M
YoY Change	57.06%	225.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.148B	$1.148B
Total Long-Term Liabilities	$487.3M	$223.6M
Total Liabilities	$1.635B	$4.949B
YoY Change	16.64%	-4.71%
SHAREHOLDERS EQUITY
Retained Earnings	$7.119B
YoY Change	-1.49%
Common Stock	$541.4M
YoY Change	0.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.709B	$8.709B
YoY Change
Total Liabilities & Shareholders Equity	$13.66B	$13.66B
YoY Change	-3.23%	-3.23%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$119.9M	-$99.92M
YoY Change	-67.92%	-187.75%
Depreciation, Depletion And Amortization	$60.75M	$140.5M
YoY Change	-22.95%	-8.68%
Cash From Operating Activities	$144.0M	$104.0M
YoY Change	284.8%	-113.49%
INVESTING ACTIVITIES
Capital Expenditures	$52.69M	$145.7M
YoY Change	-57.5%	-63.88%
Acquisitions
YoY Change
Other Investing Activities	-$140.4M	-$2.778B
YoY Change	-93.16%	-48.14%
Cash From Investing Activities	-$193.1M	-$2.924B
YoY Change	-91.12%	-49.24%
FINANCING ACTIVITIES
Cash Dividend Paid		$328.1M
YoY Change		24.66%
Common Stock Issuance & Retirement, Net		$676.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-293.1M	-76.06M
YoY Change	15.79%	-68.49%
NET CHANGE
Cash From Operating Activities	144.0M	104.0M
Cash From Investing Activities	-193.1M	-2.924B
Cash From Financing Activities	-293.1M	-76.06M
Net Change In Cash	-342.2M	-3.011B
YoY Change	-85.69%	-58.94%
FREE CASH FLOW
Cash From Operating Activities	$144.0M	$104.0M
Capital Expenditures	$52.69M	$145.7M
Free Cash Flow	$91.31M	-$41.69M
YoY Change	-205.5%	-96.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Inventory Net InventoryNet	180719000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11621000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15242000
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001084201
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	B9
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Entity File Number EntityFileNumber	001-32371
CY2023	dei	Entity Registrant Name EntityRegistrantName	SINOVAC BIOTECH LTD
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 39 Shangdi Xi Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Haidian District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100085
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	99638043
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Bankruptcy Proceedings Reporting Current EntityBankruptcyProceedingsReportingCurrent	false
CY2023	ecd	Insider Trd Policies Proc Adopted Flag InsiderTrdPoliciesProcAdoptedFlag	true
CY2023	dei	Auditor Firm AuditorFirmId	1487
CY2023	dei	Auditor Name AuditorName	Grant Thornton Zhitong Certified Public Accountants LLP
CY2023	dei	Auditor Location AuditorLocation	Beijing, China
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1270131000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4278124000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5166000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	9953042000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	7034569000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	440019000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	537118000
CY2023Q4	us-gaap	Inventory Net InventoryNet	139874000
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	10703000
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	72371000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11830556000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12126396000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	979617000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	993781000
CY2023Q4	sva	Prepaid Land Lease Payments PrepaidLandLeasePayments	65540000
CY2022Q4	sva	Prepaid Land Lease Payments PrepaidLandLeasePayments	69815000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8520000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9699000
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	24000
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	23000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	684285000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	661440000
CY2023Q4	sva	Prepayments For Acquisition Of Equipment Non Current PrepaymentsForAcquisitionOfEquipmentNonCurrent	6772000
CY2022Q4	sva	Prepayments For Acquisition Of Equipment Non Current PrepaymentsForAcquisitionOfEquipmentNonCurrent	120912000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	29790000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	71118000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45525000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58586000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7345000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2798000
CY2023Q4	us-gaap	Assets Assets	13657974000
CY2022Q4	us-gaap	Assets Assets	14114568000
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	76089000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	293000
CY2023Q4	sva	Due To Related Party Current DueToRelatedPartyCurrent	0
CY2022Q4	sva	Due To Related Party Current DueToRelatedPartyCurrent	4358000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	973949000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	905923000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	41258000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	20127000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17955000
CY2023Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	1586000
CY2022Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	15120000
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	29089000
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	141993000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5806000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5993000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1147904000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1091635000
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	200000
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0
CY2023Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	5865000
CY2022Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	4477000
CY2023Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	177817000
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	11513000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	263711000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	241526000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39271000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52516000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	439000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	240000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	487303000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	310272000
CY2023Q4	us-gaap	Liabilities Liabilities	1635207000
CY2022Q4	us-gaap	Liabilities Liabilities	1401907000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	15000
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	15000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14630813
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14630813
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14630813
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14630813
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	100000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	100000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99638043
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99638043
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99502243
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99502243
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	541258000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	540582000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-490055000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-383276000
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1539584000
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1538013000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7118516000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7225987000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8709418000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8921421000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	3313349000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	3791240000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12022767000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12712661000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13657974000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14114568000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	448269000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1492761000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19374904000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	181516000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	684456000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1072221000
CY2023	us-gaap	Gross Profit GrossProfit	266753000
CY2022	us-gaap	Gross Profit GrossProfit	808305000
CY2021	us-gaap	Gross Profit GrossProfit	18302683000
CY2023	sva	Rent Expenses Incurred To Related Party RentExpensesIncurredToRelatedParty	778000
CY2022	sva	Rent Expenses Incurred To Related Party RentExpensesIncurredToRelatedParty	819000
CY2021	sva	Rent Expenses Incurred To Related Party RentExpensesIncurredToRelatedParty	851000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	466324000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	823543000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	591167000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2638000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4268000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2967000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	344515000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	442108000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	155040000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-78720000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5213000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-977000
CY2023	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	22423000
CY2022	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	760000
CY2021	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	725000
CY2023	us-gaap	Operating Expenses OperatingExpenses	869774000
CY2022	us-gaap	Operating Expenses OperatingExpenses	1274372000
CY2021	us-gaap	Operating Expenses OperatingExpenses	749426000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-603021000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-466067000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	17553257000
CY2023	sva	Interest Expenses Incurred To Related Party InterestExpensesIncurredToRelatedParty	173000
CY2022	sva	Interest Expenses Incurred To Related Party InterestExpensesIncurredToRelatedParty	354000
CY2021	sva	Interest Expenses Incurred To Related Party InterestExpensesIncurredToRelatedParty	916000
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2260000
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1264000
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2836000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	85114000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	190818000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	102568000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	367133000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301751000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89948000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153034000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25238000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17563041000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105321000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62893000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3104130000
CY2023	us-gaap	Profit Loss ProfitLoss	-258355000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-158437000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25735000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5991431000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-99918000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	113866000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8467480000
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105900000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	107884000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8461498000
CY2023	us-gaap	Profit Loss ProfitLoss	-258355000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-280426000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-859045000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	193098000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	65900000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-472881000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-770914000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14652009000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-266184000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-370882000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6073832000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-206697000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-400032000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8578177000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	85.20
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	74.27
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99607574
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99502243
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99311551
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99607574
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114172782
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114005983
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1120125000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7735000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1033000
CY2021	us-gaap	Dividends Dividends	1904893000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	82401000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	110697000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5991431000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8467480000
CY2021	sva	Transfer To Statutory Surplus Reserves TransferToStatutorySurplusReserves	0
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13876009000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13876009000
CY2022	sva	Adjustments To Additional Paid In Capital Share Based Compensation Subscriptions Receivable AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationSubscriptionsReceivable	0
CY2022	us-gaap	Dividends Dividends	392434000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-345147000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-513898000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25735000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	113866000
CY2022	sva	Transfer To Statutory Surplus Reserves TransferToStatutorySurplusReserves	0
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12712661000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12712661000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	676000
CY2023	us-gaap	Dividends Dividends	217689000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-107747000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-106779000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-158437000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-99918000
CY2023	sva	Transfer To Statutory Surplus Reserves TransferToStatutorySurplusReserves	0
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12022767000
CY2023	us-gaap	Profit Loss ProfitLoss	-258355000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	76324000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-83010000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	265096000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	0
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	7735000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	52527000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	140004000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	70133000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2638000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4268000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2967000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-78720000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5213000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-977000
CY2023	us-gaap	Depreciation Depreciation	140467000
CY2022	us-gaap	Depreciation Depreciation	153819000
CY2021	us-gaap	Depreciation Depreciation	84446000
CY2023	sva	Amortization Of Land Use Right AmortizationOfLandUseRight	2228000
CY2022	sva	Amortization Of Land Use Right AmortizationOfLandUseRight	1749000
CY2021	sva	Amortization Of Land Use Right AmortizationOfLandUseRight	2203000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2050000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1029000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	183000
CY2023	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	22423000
CY2022	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	760000
CY2021	sva	Government Grants Recognized In Income GovernmentGrantsRecognizedInIncome	725000
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	248085000
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	0
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	0
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-82147000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-289600000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	710355000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16766000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-30382000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	334062000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	101378000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1275296000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1216717000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3265000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22519000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	143324000
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2883000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-58485000
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-288779000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	109430000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-86860000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	720858000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	4431000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	3048000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	440000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	103997000
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	8826611000
CY2023	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	144543000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-770745000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15352541000
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	243395000
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	151000
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	13511000
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	308000
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	2981000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	33436000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	676000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1033000
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	328080000
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	263171000
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	1875892000
CY2023	sva	Proceeds From Subsidiaries Financing ProceedsFromSubsidiariesFinancing	0
CY2022	sva	Proceeds From Subsidiaries Financing ProceedsFromSubsidiariesFinancing	11291000
CY2021	sva	Proceeds From Subsidiaries Financing ProceedsFromSubsidiariesFinancing	0
CY2023	sva	Proceeds From Government Grants ProceedsFromGovernmentGrants	12499000
CY2022	sva	Proceeds From Government Grants ProceedsFromGovernmentGrants	14797000
CY2021	sva	Proceeds From Government Grants ProceedsFromGovernmentGrants	4317000
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7119000
CY2023	sva	Repayments Of Loan From Noncontrolling Shareholder RepaymentsOfLoanFromNoncontrollingShareholder	4245000
CY2022	sva	Repayments Of Loan From Noncontrolling Shareholder RepaymentsOfLoanFromNoncontrollingShareholder	1486000
CY2021	sva	Repayments Of Loan From Noncontrolling Shareholder RepaymentsOfLoanFromNoncontrollingShareholder	13332000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-76063000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-241399000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1896680000
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	5575287000
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6327521000
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6567491000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	114352000
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	39000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	608000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	172000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1145000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9568000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	154000
CY2023	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	0
CY2022	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	35683000
CY2021	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	30986000
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	8222005000
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	11658465000
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	393800000
CY2021	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	719823000
CY2023	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	133767000
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	105435000
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	13663000
CY2023	sva	Distributions By Equity Method Investees DistributionsByEquityMethodInvestees	-2021000
CY2022	sva	Distributions By Equity Method Investees DistributionsByEquityMethodInvestees	0
CY2021	sva	Distributions By Equity Method Investees DistributionsByEquityMethodInvestees	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2924113000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5760470000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3023574000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-114901000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-560769000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137269000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3011080000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7333383000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10569556000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4286377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11619760000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1050204000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1275297000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4286377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11619760000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5348000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1112000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2799000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-55764000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1321563000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1487979000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) Use of Estimates</span></p><p style="margin-left:10%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In preparation of the Company’s consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates made by management include provision for product returns, allowance for doubtful accounts, inventory provisions, impairment of long-lived assets, fair value of options granted and related forfeiture rates, and realizability of deferred tax assets. On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s consolidated financial statements could be materially impacted.</span></p>
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1275297000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4286377000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11619760000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1270131000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4278124000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11608855000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5166000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10905000
CY2023Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	70888000
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	17719000
CY2023	sva	Percentage Of Sales Return Provision PercentageOfSalesReturnProvision	0.158
CY2022	sva	Percentage Of Sales Return Provision PercentageOfSalesReturnProvision	0.012
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3715000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	1553000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	6010000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	7688000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	37689000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31247000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	18243000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	45543000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	265091000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-68026000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	45543000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	265091000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-68026000
CY2023Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	524003000
CY2023Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	3720000000
CY2022Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	1490336000
CY2022Q4	sva	Cash And Cash Equivalents At Carrying Value Denominated In Rmb CashAndCashEquivalentsAtCarryingValueDenominatedInRMB	10279000000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5166000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5166000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8253000
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	65900000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	2256215000
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	7034569000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	7696827000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	9953042000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	7034569000
CY2023Q4	us-gaap	Debt Securities DebtSecurities	435841000
CY2022Q4	us-gaap	Debt Securities DebtSecurities	537500000
CY2023Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	248444000
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	123940000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	684285000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	661440000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	440019000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	537118000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	61998000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	88021000
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	43904000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	45976000
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	33972000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	46722000
CY2023Q4	us-gaap	Inventory Net InventoryNet	139874000
CY2022Q4	us-gaap	Inventory Net InventoryNet	180719000
CY2023	sva	Fixed Production Overhead To Cost Of Sales FixedProductionOverheadToCostOfSales	17300000
CY2022	sva	Fixed Production Overhead To Cost Of Sales FixedProductionOverheadToCostOfSales	97514000
CY2021	sva	Fixed Production Overhead To Cost Of Sales FixedProductionOverheadToCostOfSales	8582000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	52527000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	140004000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	70133000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1456209000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1258827000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	398267000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	265046000
CY2023Q4	sva	Property Plant And Equipment Accumulated Impairment PropertyPlantAndEquipmentAccumulatedImpairment	78325000
CY2022Q4	sva	Property Plant And Equipment Accumulated Impairment PropertyPlantAndEquipmentAccumulatedImpairment	0
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	979617000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	993781000
CY2023	us-gaap	Depreciation Depreciation	140467000
CY2022	us-gaap	Depreciation Depreciation	153819000
CY2021	us-gaap	Depreciation Depreciation	84446000
CY2023	sva	Gain Loss On Sale Of Property Plant Equipment Excluding Impairment GainLossOnSaleOfPropertyPlantEquipmentExcludingImpairment	-395000
CY2022	sva	Gain Loss On Sale Of Property Plant Equipment Excluding Impairment GainLossOnSaleOfPropertyPlantEquipmentExcludingImpairment	-5213000
CY2021	sva	Gain Loss On Sale Of Property Plant Equipment Excluding Impairment GainLossOnSaleOfPropertyPlantEquipmentExcludingImpairment	-977000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2050000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1029000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	183000
CY2023Q4	sva	Finance Leases Current And Noncurrent FinanceLeasesCurrentAndNoncurrent	0
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.049
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	7730000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9102000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	16220000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9516000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3158000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1464000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	7955000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	13992000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	187000
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	8015000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	973949000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8024000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6038000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5961000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6221000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6210000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	23338000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55792000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10715000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	45077000
CY2023	us-gaap	Short Term Lease Payments ShortTermLeasePayments	287000
CY2023Q4	sva	Lessee Operating Lease Lease Not Yet Commenced LesseeOperatingLeaseLeaseNotYetCommenced	0
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	76089000
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	293000
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	177817000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	11513000
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	253906000
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	11806000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	76089000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	114949000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	31106000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2433000
CY2023Q4	sva	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	29329000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	253906000
CY2023Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.028
CY2022Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0588
CY2021Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0465
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	2260000
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	1264000
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	3023000
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	554000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	643855000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	311440000
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	9435000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4390760000
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	17291000
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	19825000
CY2023Q4	sva	Capital Expenditures Incurred But Not Yet Paid Machinery And Equipment CapitalExpendituresIncurredButNotYetPaidMachineryAndEquipment	50040000
CY2022Q4	sva	Capital Expenditures Incurred But Not Yet Paid Machinery And Equipment CapitalExpendituresIncurredButNotYetPaidMachineryAndEquipment	67475000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	250565000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242528000
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1619000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1784000
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	656000
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	254302000
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	488000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	469000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	905923000
CY2008	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2008	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	139608000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	48500000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	94372000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-292642000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-23262000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17468669000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153034000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25238000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17563041000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28997000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20117000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2839034000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	76324000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-83010000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	265096000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105321000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62893000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3104130000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153034000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25238000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17563041000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-75942000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6310000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1665000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-5303000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	40899000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	84008000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	159235000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	33920000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	55748000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	227821000
CY2023	sva	Income Tax Reconciliation Effect Of Preferential Tax Treatment IncomeTaxReconciliationEffectOfPreferentialTaxTreatment	10515000
CY2022	sva	Income Tax Reconciliation Effect Of Preferential Tax Treatment IncomeTaxReconciliationEffectOfPreferentialTaxTreatment	-4213000
CY2021	sva	Income Tax Reconciliation Effect Of Preferential Tax Treatment IncomeTaxReconciliationEffectOfPreferentialTaxTreatment	1774595000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	83704000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	12707000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4135000
CY2023	sva	Income Tax Reconciliation Effect Of Withholding Tax On Distributable Profits Of Subsidiaries IncomeTaxReconciliationEffectOfWithholdingTaxOnDistributableProfitsOfSubsidiaries	-36921000
CY2022	sva	Income Tax Reconciliation Effect Of Withholding Tax On Distributable Profits Of Subsidiaries IncomeTaxReconciliationEffectOfWithholdingTaxOnDistributableProfitsOfSubsidiaries	-59006000
CY2021	sva	Income Tax Reconciliation Effect Of Withholding Tax On Distributable Profits Of Subsidiaries IncomeTaxReconciliationEffectOfWithholdingTaxOnDistributableProfitsOfSubsidiaries	426737000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	379000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	522000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	6190000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105321000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62893000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3104130000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	9747000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	16573000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	83309000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	64283000
CY2023Q4	sva	Deferred Tax Assets Tax Deferred Expense Government Grants Current DeferredTaxAssetsTaxDeferredExpenseGovernmentGrantsCurrent	1183000
CY2022Q4	sva	Deferred Tax Assets Tax Deferred Expense Government Grants Current DeferredTaxAssetsTaxDeferredExpenseGovernmentGrantsCurrent	2935000
CY2023Q4	sva	Deferred Tax Assets Fixed Assets DeferredTaxAssetsFixedAssets	-29122000
CY2022Q4	sva	Deferred Tax Assets Fixed Assets DeferredTaxAssetsFixedAssets	-12673000
CY2023Q4	sva	Deferred Tax Assets Operating Loss Carry Forwards Noncurrent DeferredTaxAssetsOperatingLossCarryForwardsNoncurrent	65338000
CY2022Q4	sva	Deferred Tax Assets Operating Loss Carry Forwards Noncurrent DeferredTaxAssetsOperatingLossCarryForwardsNoncurrent	16961000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100665000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16961000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	29790000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	71118000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	83704000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16961000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100665000
CY2023Q4	sva	Deferred Tax Liabilities Represents Withholding Tax DeferredTaxLiabilitiesRepresentsWithholdingTax	234382000
CY2023	sva	Withholding Tax Rate WithholdingTaxRate	0.05
CY2023	sva	Withholding Tax Rate Before Treaty Benefits WithholdingTaxRateBeforeTreatyBenefits	0.10
CY2023	sva	Withholding Tax Rate After Treaty Benefits WithholdingTaxRateAfterTreatyBenefits	0.05
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	275000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	561000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	81000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	194000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	286000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	275000
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	106000
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	135000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	64000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	275000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	81000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	275000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	257025000
CY2023	sva	Proceeds From Government Grants Received ProceedsFromGovernmentGrantsReceived	8571000
CY2022	sva	Proceeds From Government Grants Received ProceedsFromGovernmentGrantsReceived	6984000
CY2021	sva	Proceeds From Government Grants Received ProceedsFromGovernmentGrantsReceived	2660000
CY2023Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	1586000
CY2022Q4	sva	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	15120000
CY2023Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	5865000
CY2022Q4	sva	Deferred Government Grants Noncurrent DeferredGovernmentGrantsNoncurrent	4477000
CY2023Q4	sva	Deferred Government Grants Current And Noncurrent DeferredGovernmentGrantsCurrentAndNoncurrent	7451000
CY2022Q4	sva	Deferred Government Grants Current And Noncurrent DeferredGovernmentGrantsCurrentAndNoncurrent	19597000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14630813
CY2023	sva	Common Stock Vote Per Share CommonStockVotePerShare	1
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99638043
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99502243
CY2018Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	2000000
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	172500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.98
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	sva	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	135800
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.98
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	202342000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	36700
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.98
CY2023	sva	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Totalintrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalintrinsicValue	-54683000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7735000
CY2023	sva	Appropriation Of Net Income After Taxes To Statutory Surplus Reserve Fund Required Minimum Percentage AppropriationOfNetIncomeAfterTaxesToStatutorySurplusReserveFundRequiredMinimumPercentage	0.10
CY2023	sva	Reserve Level Threshold For Mandatory Transfer Percentage ReserveLevelThresholdForMandatoryTransferPercentage	0.50
CY2023Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	1539584000
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	1538013000
CY2023Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	1937250000
CY2023Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	12672000000
CY2022Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	1930199000
CY2022Q4	sva	Restricted Paid In Capital Additional Paid In Capital And Statutory Surplus Reserves RestrictedPaidInCapitalAdditionalPaidInCapitalAndStatutorySurplusReserves	12640000000
CY2023Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	5008306000
CY2022Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	5873741000
CY2023	us-gaap	Profit Loss ProfitLoss	-258355000
CY2022	us-gaap	Profit Loss ProfitLoss	88131000
CY2021	us-gaap	Profit Loss ProfitLoss	14458911000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-158437000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-25735000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5991431000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-99918000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	113866000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8467480000
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	5982000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105900000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	107884000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8461498000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-99918000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	113866000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8467480000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99607574
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99502243
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99311551
CY2023	sva	Incremental Common Shares Attributable To Share Based Payment Arrangements And Preferred Shares IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndPreferredShares	0
CY2022	sva	Incremental Common Shares Attributable To Share Based Payment Arrangements And Preferred Shares IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndPreferredShares	14670539
CY2021	sva	Incremental Common Shares Attributable To Share Based Payment Arrangements And Preferred Shares IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsAndPreferredShares	14694432
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99607574
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114172782
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114005983
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	85.2
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	74.27
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q4	us-gaap	Assets Assets	13657974000
CY2022Q4	us-gaap	Assets Assets	14114568000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	448269000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1492761000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19374904000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	448269000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1492761000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19374904000
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0
CY2023	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	135000
CY2023	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	124117
CY2022	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	68000
CY2022	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	60000
CY2021	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	72000
CY2021	sva	Milestone Fee Recorded Cost Of Goods Sold MilestoneFeeRecordedCostOfGoodsSold	60000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0

Files In Submission

Name	View Source	Status
R105.htm	Edgar Link	pending
0000950170-24-049936-index-headers.html	Edgar Link	pending
0000950170-24-049936-index.html	Edgar Link	pending
0000950170-24-049936.txt	Edgar Link	pending
0000950170-24-049936-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img57734221_0.jpg	Edgar Link	pending
img57734221_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sva-20231231.htm	Edgar Link	pending
sva-20231231.xsd	Edgar Link	pending
sva-ex12_1.htm	Edgar Link	pending
sva-ex12_2.htm	Edgar Link	pending
sva-ex13_1.htm	Edgar Link	pending
sva-ex13_2.htm	Edgar Link	pending
sva-ex15_1.htm	Edgar Link	pending
sva-ex8_1.htm	Edgar Link	pending
sva-ex97_1.htm	Edgar Link	pending
sva-20231231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SVA
SINOVAC BIOTECH LTD Stock $sva

2023 Q4 Form 20-F Financial Statement

#000095017024049936 Filed on April 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SVA SINOVAC BIOTECH LTD Stock $sva

2023 Q4 Form 20-F Financial Statement

#000095017024049936 Filed on April 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SVA
SINOVAC BIOTECH LTD Stock $sva